Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood. (Q51744172)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Rosalba Miceli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Michela Casanova

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Filippo Spreafico

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Marta Podda

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Andrea Anichini

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Iacopo Sardi

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Lorenza Gandola

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Veronica Biassoni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Elisabetta Schiavello

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Felice Giangaspero

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Manila Antonelli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Paolo Potepan

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Carlo Alfredo Clerici

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Loris De Cecco

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Piergiorgio Modena

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Emilia Pecori

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Francesca Romana Buttarelli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Bianca Pollo

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Raffaele Nunziata

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Udo Bode

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Ferdinand Bach

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Monika Warmuth-Metz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

3 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

12 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

305-312

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24696052%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11060-014-1428-z

12 March 2020

exact match

0 references

cites work

Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Advances toward an understanding of brainstem gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Diffuse brainstem glioma in children: critical review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Nimotuzumab treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

MRI as a central component of clinical trials analysis in brainstem glioma: a report from the Pediatric Brain Tumor Consortium (PBTC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Genomic aberrations in pediatric diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Morphologic characteristics and immunohistochemical profile of diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Nimotuzumab for pediatric diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: report from a phase I/II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Therapeutic efficacy of vinorelbine against pediatric and adult central nervous system tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Gefitinib enhances cytotoxicities of antimicrotubule agents in non-small-cell lung cancer cells exhibiting no sensitizing epidermal growth factor receptor mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Palliative reirradiation for progressive diffuse intrinsic pontine glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Vinorelbine in previously treated advanced childhood sarcomas: evidence of activity in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Hypofractionated radiotherapy in the treatment of diffuse intrinsic pontine glioma in children: a single institution's experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

MR imaging assessment of tumor perfusion and 3D segmented volume at baseline, during treatment, and at tumor progression in children with newly diagnosed diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Young age may predict a better outcome for children with diffuse pontine glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-014-1428-Z

In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence

21 January 2018

1 reference

12 December 2020

Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine.

1 reference

12 December 2020

Effects of vinorelbine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitro

1 reference

12 December 2020

ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma

1 reference

12 December 2020